Maturity testing with preterm premature rupture of the membranes

Clinics in Perinatology

Volumn 28, Issue 4, 2001, Pages 819-836

  Spinnato II, Joseph A ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; BETAMETHASONE; CORTICOSTEROID; DEXAMETHASONE; ERYTHROMYCIN; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLGLYCEROL; PLACEBO;

AMNION FLUID ANALYSIS; AMNIONITIS; ANTIBIOTIC PROPHYLAXIS; BRAIN HEMORRHAGE; CLINICAL TRIAL; CORTICOSTEROID THERAPY; FETUS LUNG MATURITY; HUMAN; HYALINE MEMBRANE DISEASE; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN SEPSIS; PREDICTION; PREMATURE FETUS MEMBRANE RUPTURE; PRIORITY JOURNAL; RACE DIFFERENCE; REVIEW;

EID: 0035180707     PISSN: 00955108     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0095-5108(03)00080-0     Document Type: Review

References (55)

1. Ampicillin prophylaxis in preterm premature rupture of the membranes: A prospective randomized study
2. Density of amniotic fluid lamellar bodies: A comparison with classical methods for the assessment of fetal lung maturity
3. A retrospective study on the effects of steroid administration and prolongation of the latent phase in patients with preterm premature rupture of the membranes
4. Lamellar body counts for rapid fetal lung maturity testing
5. Amniostat-FLM: An initial clinical trial with both vaginal pool and amniocentesis samples
6. Fetus, placenta and newborn: The relationship between premature rupture of the membranes and the respiratory distress syndrome. An update and plan of management
7. Racial differences in the predictive value of the TDx fetal lung maturity assay
8. Lamellar body number density and the prediction of respiratory distress
9. Use of amniotic fluid analysis in the management of preterm rupture of the membranes
10. Antenatal steroids and intraventricular hemorrhage after premature rupture of membranes at 24-28 weeks' gestation
11. Expectant management of preterm ruptured membranes: Effects of antimicrobial therapy
12. Effect of antenatal desamethasone administration on the prevention of respiratory distress syndrome
13. Intentional delivery versus expectant management with preterm ruptured membranes at 30-34 weeks' gestation
14. Amniotic fluid lamellar body count: A rapid and reliable fetal lung maturity test
15. Comparison of amniotic fluid lung maturity profiles in paired vaginal and amniocentesis specimens
16. Effectiveness of antenatal steroids in obstetric subgroups
17. Amniotic fluid phospholipids after maternal administration of desamethasone
18. Prospective randomized study of corticosteroids in the management of premature rupture of the membranes and the premature gestation
19. Fetal maturity cascade: A rapid and cost-effective method for fetal lung maturity testing
20. Morbidity in the preterm infant with mature lung indices
21. A comparison of the accuracy of the TDx-FLM assay, lecithin-sphingomyelin ratio, and phosphatidylglycerol in the prediction of neonatal respiratory distress syndrome
22. Comparison of lecithin:sphingomyelin ratio, fluorescence polarization, and phosphatidylglycerol in the amniotic fluid in the prediction of respiratory distress syndrome
23. Immature lecithin/sphingomyelin ratios and neonatal respiratory course
24. Clinical and economic considerations associated with testing for fetal lung maturity
25. Role of the TDx FLM assay in fetal lung maturity
26. The pattern of change in the lecithin/sphingomyelin ratio in patients with preterm premature rupture of membranes: An observational study
27. Comparison of the accuracy of fetal pulmonary maturity testing using transvaginally and transabdominally collected amniotic fluid
28. Testing for fetal pulmonary maturity: ROC analysis involving covariates, verification bias, and combination testing
29. Antibiotic therapy in preterm premature rupture of the membranes: A randomized prospective double-blind trial
30. Instruments and methods: Standard lecithin/sphingomyelin and phosphatidylglycerol techniques compared with immunologic slide test
31. Ability of normal vaginal flora to produce detectable phosphatidylglycerol in amniotic fluid in vitro
32. Preterm premature ruptured membranes: A randomized trial of steroids after treatment with antibiotics
33. Use of amniostat-FLM in detecting the presence of phosphatidylglycerol in vaginal pool samples in preterm premature rupture of membranes
34. Comparison of the lumadex-foam stability index test, lecithin ratio, and simple shake test for fetal lung maturity
35. Antimicrobial therapy in preterm premature rupture of membranes: Results of a prospective, double-blind, placebo-controlled trial of erythromycin
36. Induction versus expectant management in premature rupture of the membranes with mature amniotic fluid at 32 to 36 weeks: A randomized trial
37. Antibiotic therapy for reduction of infant morbidity after preterm premature rupture of the membranes
38. Erythromycin therapy in preterm premature rupture of the membranes: A prospective, randomized trial of 220 patients
39. Use of ampicillin and corticosteroids in premature rupture of membranes: A randomized study
40. The effects of vaginal contamination on two pulmonary phospholipid assays
41. The cellular mechanism of glucocorticoid acceleration of fetal lung maturation: Fibroblast-pneumonocyte factor stimulates choline-phosphate cytidylyltransferase activity
42. Racial differences in predictive value of the lecithin/sphingomyelin ratio
43. Multicenter evaluation of TDx test for assessing fetal lung maturity
44. Bacteria causing false positive test for phosphatidylglycerol in amniotic fluid
45. Comparison of phospholipids in vaginal and amniocentesis specimens of patients with premature rupture of membranes
46. Influence of gestational age on prediction of fetal lung maturity by flourescence polarization of amniotic fluid
47. Glucocorticoid effects on rabbit fetal lung maturation in vivo: An ultrastructural morphometric study
48. Infrequency of pulmonary immaturity in an indigent population with preterm premature rupture of the membranes
49. Preterm premature rupture of the membranes with fetal pulmonary maturity present: A prospective study
50. Management of preterm premature rupture of membranes: Assessing amniotic fluid in the vagina for phosphatidylglycerol
51. Evaluation of the new Amniostat-FLM test for the detection of phosphatidylglycerol in contaminated fluids
52. The effects of antenatal steroid use in premature rupture of membranes
53. Effectiveness of antenatal corticosteroid administration after preterm premature rupture of the membranes
54. Amniostat FLM: A new technique for detection of phosphatidylglycerol in amniotic fluid
55. Neonatal morbidity after preterm delivery in the presence of documented lung maturity